Nucleic Acid Amplification Testing and Sequencing Combined with Acid-Fast Staining in Needle Biopsy Lung Tissues for the Diagnosis of Smear-Negative Pulmonary Tuberculosis

Background Smear-negative pulmonary tuberculosis (PTB) is common and difficult to diagnose. In this study, we investigated the diagnostic value of nucleic acid amplification testing and sequencing combined with acid-fast bacteria (AFB) staining of needle biopsy lung tissues for patients with suspected smear-negative PTB. Methods Patients with suspected smear-negative PTB who underwent percutaneous transthoracic needle biopsy between May 1, 2012, and June 30, 2015, were enrolled in this retrospective study. Patients with AFB in sputum smears were excluded. All lung biopsy specimens were fixed in formalin, embedded in paraffin, and subjected to acid-fast staining and tuberculous polymerase chain reaction (TB-PCR). For patients with positive AFB and negative TB-PCR results in lung tissues, probe assays and 16S rRNA sequencing were used for identification of nontuberculous mycobacteria (NTM). The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy of PCR and AFB staining were calculated separately and in combination. Results Among the 220 eligible patients, 133 were diagnosed with TB (men/women: 76/57; age range: 17–80 years, confirmed TB: 9, probable TB: 124). Forty-eight patients who were diagnosed with other specific diseases were assigned as negative controls, and 39 patients with indeterminate final diagnosis were excluded from statistical analysis. The sensitivity, specificity, PPV, NPV, and accuracy of histological AFB (HAFB) for the diagnosis of smear-negative were 61.7% (82/133), 100% (48/48), 100% (82/82), 48.5% (48/181), and 71.8% (130/181), respectively. The sensitivity, specificity, PPV, and NPV of histological PCR were 89.5% (119/133), 95.8% (46/48), 98.3% (119/121), and 76.7% (46/60), respectively, demonstrating that histological PCR had significantly higher accuracy (91.2% [165/181]) than histological acid-fast staining (71.8% [130/181]), P < 0.001. Parallel testing of histological AFB staining and PCR showed the sensitivity, specificity, PPV, NPV, and accuracy to be 94.0% (125/133), 95.8% (46/48), 98.4% (125/127), 85.2% (46/54), and 94.5% (171/181), respectively. Among patients with positive AFB and negative PCR results in lung tissue specimens, two were diagnosed with NTM infections (Mycobacterium avium-intracellulare complex and Mycobacterium kansasii). Conclusion Nucleic acid amplification testing combined with acid-fast staining in lung biopsy tissues can lead to early and accurate diagnosis in patients with smear-negative pulmonary tuberculosis. For patients with positive histological AFB and negative tuberculous PCR results in lung tissue, NTM infection should be suspected and could be identified by specific probe assays or 16S rRNA sequencing.

[1]  X. Nassif,et al.  RAPID DIAGNOSIS OF TUBERCULOSIS BY AMPLIFICATION OF MYCOBACTERIAL DNA IN CLINICAL SAMPLES , 1989, The Lancet.

[2]  J. Hartley,et al.  Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. , 1990, Gene.

[3]  J. T. Crawford,et al.  Detection of Mycobacterium tuberculosis in sputum samples using a polymerase chain reaction. , 1991, The American review of respiratory disease.

[4]  T. Frank,et al.  Detection and species identification of mycobacteria in paraffin sections of lung biopsy specimens by the polymerase chain reaction. , 1993, American journal of clinical pathology.

[5]  T. Schaberg,et al.  Clinical evaluation of a Mycobacterium tuberculosis PCR assay , 1995, Journal of clinical microbiology.

[6]  J. Bates,et al.  Polymerase chain reaction to detect Mycobacterium tuberculosis in histologic specimens. , 1998, American journal of respiratory and critical care medicine.

[7]  G. Marchetti,et al.  Nested polymerase chain reaction for Mycobacterium tuberculosis IS6110 sequence on formalin-fixed paraffin-embedded tissues with granulomatous diseases for rapid diagnosis of tuberculosis. , 1998, American journal of clinical pathology.

[8]  C. Ng,et al.  Molecular detection of Mycobacterium tuberculosis in tissues showing granulomatous inflammation without demonstrable acid-fast bacilli. , 2000, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[9]  Tomoyuki Murakami,et al.  Sensitivity of acid-fast staining for Mycobacterium tuberculosis in formalin-fixed tissue. , 2002, American journal of respiratory and critical care medicine.

[10]  L. Landraud,et al.  [Value of PCR amplification from formalin-fixed paraffin-embedded tissues in the diagnosis of Mycobacterium tuberculosis infection]. , 2003, Annales de pathologie.

[11]  S. Hamilton-Dutoit,et al.  Improved diagnosis of mycobacterial infections in formalin‐fixed and paraffin‐embedded sections with nested polymerase chain reaction , 2005, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[12]  D. Moore,et al.  Reduction in turnaround time for laboratory diagnosis of pulmonary tuberculosis by routine use of a nucleic acid amplification test. , 2005, Diagnostic microbiology and infectious disease.

[13]  T. Shinnick,et al.  National plan for reliable tuberculosis laboratory services using a systems approach. Recommendations from CDC and the Association of Public Health Laboratories Task Force on Tuberculosis Laboratory Services. , 2005, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[14]  J. Moisan,et al.  Detection of mycobacteria using the polymerase chain reaction , 1992, European Journal of Clinical Microbiology and Infectious Diseases.

[15]  N. Beeching,et al.  The clinical impact of nucleic acid amplification tests on the diagnosis and management of tuberculosis in a British hospital , 2007, Thorax.

[16]  J. Palomino,et al.  New simple decontamination method improves microscopic detection and culture of mycobacteria in clinical practice , 2008, Infection and drug resistance.

[17]  J. Park,et al.  Nested PCR in lung tissue for diagnosis of pulmonary tuberculosis , 2009, European Respiratory Journal.

[18]  T. Marras,et al.  Isolation prevalence of pulmonary nontuberculous mycobacteria in Ontario in 2007. , 2011, Canadian respiratory journal.

[19]  D. Shingadia The Diagnosis of Tuberculosis , 2012, The Pediatric infectious disease journal.

[20]  S. Holland,et al.  Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. , 2012, American journal of respiratory and critical care medicine.

[21]  T. Marras,et al.  Pulmonary Nontuberculous Mycobacterial Disease, Ontario, Canada, 1998–2010 , 2013, Emerging infectious diseases.

[22]  J. K. Kim,et al.  Identification and Distribution of Nontuberculous Mycobacteria from 2005 to 2011 in Cheonan, Korea , 2013, Tuberculosis and respiratory diseases.

[23]  Chong-Jen Yu,et al.  Pulmonary Infection and Colonization with Nontuberculous Mycobacteria, Taiwan, 2000–2012 , 2014, Emerging infectious diseases.

[24]  S. Montenegro,et al.  [Efficacy of PCR for the differential diagnosis of tuberculosis in granulomatous lesions of paraffin-embedded formalin fixed tissues]. , 2014, Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia.

[25]  Jie Wu,et al.  Increase in Nontuberculous Mycobacteria Isolated in Shanghai, China: Results from a Population-Based Study , 2014, PloS one.

[26]  M. Kumar,et al.  Prevalence of Nontuberculous Mycobacteria among Extrapulmonary Tuberculosis Cases in Tertiary Care Centers in Northern India , 2015, BioMed research international.

[27]  W. Lu,et al.  The Epidemiology and Geographic Distribution of Nontuberculous Mycobacteria Clinical Isolates from Sputum Samples in the Eastern Region of China , 2015, PLoS neglected tropical diseases.

[28]  P. Tian,et al.  CT-guided percutaneous transthoracic needle biopsy for paramediastinal and nonparamediastinal lung lesions , 2016, Medicine.